Illuminating the dark phosphoproteome
暂无分享,去创建一个
David E. James | Sean J. Humphrey | Benjamin L. Parker | D. James | E. Needham | B. Parker | T. Burykin | Elise J. Needham | Timur Burykin
[1] Laura A. Sullivan,et al. Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.
[2] N. Kelleher,et al. Top Down proteomics: facts and perspectives. , 2014, Biochemical and biophysical research communications.
[3] S. Gygi,et al. Mass spectrometry based method to increase throughput for kinome analyses using ATP probes. , 2013, Analytical chemistry.
[4] K. Nakayama,et al. Reconstruction of insulin signal flow from phosphoproteome and metabolome data. , 2014, Cell reports.
[5] C. Kahn,et al. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats. , 1989, The Journal of clinical investigation.
[6] Levi A Garraway,et al. A Convergence-Based Framework for Cancer Drug Resistance. , 2018, Cancer cell.
[7] D. Sabatini,et al. The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.
[8] J. Chin,et al. Light-Activated Kinases Enable Temporal Dissection of Signaling Networks in Living Cells , 2011, Journal of the American Chemical Society.
[9] Matthias Mann,et al. BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes , 2018, Nature Methods.
[10] R. Aebersold. A mass spectrometric journey into protein and proteome research , 2003, Journal of the American Society for Mass Spectrometry.
[11] Gaudenz Danuser,et al. LOVTRAP, An Optogenetic System for Photo-induced Protein Dissociation , 2016, Nature Methods.
[12] B. Druker,et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. , 2000, The Journal of pharmacology and experimental therapeutics.
[13] M. Birnbaum,et al. Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.
[14] Paul J. Wang,et al. The CREB leucine zipper regulates CREB phosphorylation, cardiomyopathy, and lethality in a transgenic model of heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.
[15] Karl Mechtler,et al. Unambiguous Phosphosite Localization using Electron-Transfer/Higher-Energy Collision Dissociation (EThcD) , 2013, Journal of proteome research.
[16] Sean J. Humphrey,et al. Protein Phosphorylation: A Major Switch Mechanism for Metabolic Regulation , 2015, Trends in Endocrinology & Metabolism.
[17] Holger Conzelmann,et al. Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. , 2011, Molecular cell.
[18] S. Mohammed,et al. Signal Transduction Reaction Monitoring Deciphers Site-Specific PI3K-mTOR/MAPK Pathway Dynamics in Oncogene-Induced Senescence. , 2015, Journal of proteome research.
[19] M. Mann,et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. , 2008, Molecular cell.
[20] M. Mann,et al. Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. , 2010, Journal of proteome research.
[21] M. Clausen,et al. Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. , 2016, Drug discovery today.
[22] P. Bork,et al. Linear Motif Atlas for Phosphorylation-Dependent Signaling , 2008, Science Signaling.
[23] Heiko Horn,et al. In Vivo Phosphoproteomics Analysis Reveals the Cardiac Targets of β-Adrenergic Receptor Signaling , 2013, Science Signaling.
[24] K. Shokat,et al. Engineering Src family protein kinases with unnatural nucleotide specificity. , 1998, Chemistry & biology.
[25] Christian Stolte,et al. SnapShot: Insulin/IGF1 Signaling , 2015, Cell.
[26] M. Mann,et al. Higher-energy C-trap dissociation for peptide modification analysis , 2007, Nature Methods.
[27] Bin Fang,et al. Polypharmacology-based ceritinib repurposing using integrated functional proteomics. , 2017, Nature chemical biology.
[28] Michael L. Gatza,et al. Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.
[29] P. Beltrão,et al. Identifications of Putative PKA Substrates with Quantitative Phosphoproteomics and Primary-Sequence-Based Scoring. , 2017, Journal of proteome research.
[30] M. Mann,et al. System-wide Perturbation Analysis with Nearly Complete Coverage of the Yeast Proteome by Single-shot Ultra HPLC Runs on a Bench Top Orbitrap* , 2011, Molecular & Cellular Proteomics.
[31] Sean J Humphrey,et al. High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics , 2015, Nature Biotechnology.
[32] James E. Ferrell,et al. Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.
[33] A. Burlingame,et al. Mass Spectrometry-Based Detection and Assignment of Protein Posttranslational Modifications , 2014, ACS chemical biology.
[34] A. Heck,et al. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells , 2011, Molecular systems biology.
[35] A. Heck,et al. Implementation of Ultraviolet Photodissociation on a Benchtop Q Exactive Mass Spectrometer and Its Application to Phosphoproteomics. , 2016, Analytical chemistry.
[36] Alma L Burlingame,et al. A semisynthetic epitope for kinase substrates , 2007, Nature Methods.
[37] J. Ferrell,et al. Ultrasensitivity part II: multisite phosphorylation, stoichiometric inhibitors, and positive feedback. , 2014, Trends in biochemical sciences.
[38] S. Kajimura,et al. Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure. , 2015, Cell metabolism.
[39] P. Beltrão,et al. Uncovering Phosphorylation-Based Specificities through Functional Interaction Networks* , 2015, Molecular & Cellular Proteomics.
[40] David E James,et al. A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. , 2015, Cell reports.
[41] Matthias Mann,et al. EASI-tag enables accurate multiplexed and interference-free MS2-based proteome quantification , 2017, bioRxiv.
[42] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[43] J. Brodbelt,et al. 193 nm Ultraviolet Photodissociation Mass Spectrometry for Phosphopeptide Characterization in the Positive and Negative Ion Modes. , 2016, Journal of proteome research.
[44] B. Kholodenko,et al. Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades , 2004, The Journal of cell biology.
[45] Bin Fang,et al. Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells , 2013, Proceedings of the National Academy of Sciences.
[46] Andrew R. Jones,et al. ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.
[47] Ruedi Aebersold,et al. Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling , 2013, Cell.
[48] P. Strålfors,et al. Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes* , 2005, Journal of Biological Chemistry.
[49] Matthias Mann,et al. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases , 2016, eLife.
[50] Tomohiro Suzuki,et al. Forward-genetics analysis of sleep in randomly mutagenized mice , 2016, Nature.
[51] Stefan Knapp,et al. Recently targeted kinases and their inhibitors-the path to clinical trials. , 2014, Current opinion in pharmacology.
[52] Martin Kircher,et al. Deep proteome and transcriptome mapping of a human cancer cell line , 2011, Molecular systems biology.
[53] B. Kuster,et al. Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. , 2012, Journal of proteomics.
[54] D E Koshland,et al. Energy expenditure in the control of biochemical systems by covalent modification. , 1987, The Journal of biological chemistry.
[55] Bin Zhang,et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..
[56] David E James,et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest , 2017, Proceedings of the National Academy of Sciences.
[57] I. Lax,et al. The Selectivity of Receptor Tyrosine Kinase Signaling Is Controlled by a Secondary SH2 Domain Binding Site , 2009, Cell.
[58] C. Landry,et al. Weak functional constraints on phosphoproteomes. , 2009, Trends in genetics : TIG.
[59] Albert J R Heck,et al. PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks. , 2015, Journal of proteome research.
[60] Chin-Rang Yang,et al. Systems-level identification of PKA-dependent signaling in epithelial cells , 2017, Proceedings of the National Academy of Sciences.
[61] David E. James,et al. Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2 , 2013, Cell metabolism.
[62] Matthew E Berginski,et al. Coral: Clear and Customizable Visualization of Human Kinome Data. , 2018, Cell systems.
[63] J. Fitzgibbon,et al. Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells. , 2017, Leukemia.
[64] Tony Pawson,et al. NetworKIN: a resource for exploring cellular phosphorylation networks , 2007, Nucleic Acids Res..
[65] Steven P Gygi,et al. Phosphoproteomic Analysis of the Developing Mouse Brain*S , 2004, Molecular & Cellular Proteomics.
[66] Sandhya Rani,et al. Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..
[67] Dhruv Chauhan,et al. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation* , 2015, The Journal of Biological Chemistry.
[68] Gary D. Bader,et al. An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.
[69] Ronald J. Moore,et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.
[70] S. Gygi,et al. Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution , 2009, Science.
[71] Man Kit Cheung,et al. Human proteins with target sites of multiple post-translational modification types are more prone to be involved in disease. , 2014, Journal of proteome research.
[72] B. Searle,et al. “Plug-and-play” investigation of the human phosphoproteome by targeted high-resolution mass spectrometry , 2016, Nature Methods.
[73] Chunaram Choudhary,et al. Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae , 2014, Molecular systems biology.
[74] M. Tomita,et al. Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance* , 2012, The Journal of Biological Chemistry.
[75] G. Hart,et al. Cross-talk between GlcNAcylation and phosphorylation: Site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc , 2008, Proceedings of the National Academy of Sciences.
[76] Matthias Mann,et al. In vivo brain GPCR signaling elucidated by phosphoproteomics , 2018, Science.
[77] Sean J. Humphrey,et al. Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion , 2016, Nature Communications.
[78] Chi-Ying F. Huang,et al. Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] M. Mann,et al. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics , 2004, Nature Biotechnology.
[80] J. Cox,et al. Proteomics strategy for quantitative protein interaction profiling in cell extracts , 2009, Nature Methods.
[81] Jean Yee Hwa Yang,et al. Positive-unlabeled ensemble learning for kinase substrate prediction from dynamic phosphoproteomics data , 2015, Bioinform..
[82] J. Gribben,et al. Empirical inference of circuitry and plasticity in a kinase signaling network , 2015, Proceedings of the National Academy of Sciences.
[83] Tony Hunter,et al. pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification. , 2017, Current opinion in cell biology.
[84] P. Cohen,et al. The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.
[85] M. Mann,et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. , 2014, Cell reports.
[86] Cornelia Schönbauer,et al. Systematic genetic analysis of muscle morphogenesis and function in Drosophila , 2010, Nature.
[87] Jan C. Refsgaard,et al. From Phosphosites to Kinases. , 2016, Methods in molecular biology.
[88] S. Tooze,et al. siRNA Screening of the Kinome Identifies ULK1 as a Multidomain Modulator of Autophagy* , 2007, Journal of Biological Chemistry.
[89] Emily J. Girard,et al. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells. , 2015, Cell reports.
[90] Dario R Alessi,et al. Kinase drug discovery--what's next in the field? , 2013, ACS chemical biology.
[91] J. Shabanowitz,et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae , 2002, Nature Biotechnology.
[92] M. Mann,et al. Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.
[93] Waltraud X. Schulze,et al. A Novel Proteomic Screen for Peptide-Protein Interactions* , 2004, Journal of Biological Chemistry.
[94] Hui Li,et al. Control of muscle formation by the fusogenic micropeptide myomixer , 2017, Science.
[95] P. Cohen,et al. The origins of protein phosphorylation , 2002, Nature Cell Biology.
[96] P. Alam. ‘L’ , 2021, Composites Engineering: An A–Z Guide.
[97] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[98] S. Ross,et al. New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome. , 2018, Cancer research.
[99] Toru Okamoto,et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.
[100] E. Birney,et al. Pfam: the protein families database , 2013, Nucleic Acids Res..
[101] P. Alam. ‘S’ , 2021, Composites Engineering: An A–Z Guide.
[102] Mike Tyers,et al. Machine Learning of Global Phosphoproteomic Profiles Enables Discrimination of Direct versus Indirect Kinase Substrates* , 2017, Molecular & Cellular Proteomics.
[103] Michael J. MacCoss,et al. A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations , 2017, bioRxiv.
[104] A. Biankin,et al. Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling* , 2016, Molecular & Cellular Proteomics.
[105] Nolan J Hoffman,et al. Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. , 2015, Cell metabolism.
[106] David E James,et al. High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform , 2018, Nature Protocols.
[107] M. Yanagisawa,et al. Quantitative phosphoproteomic analysis of the molecular substrates of sleep need , 2018, Nature.
[108] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[109] G. Drewes,et al. Tracking cancer drugs in living cells by thermal profiling of the proteome , 2014, Science.
[110] T. Hunter. The age of crosstalk: phosphorylation, ubiquitination, and beyond. , 2007, Molecular cell.
[111] K. Kaestner,et al. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .
[112] Tony Pawson,et al. Temporal regulation of EGF signaling networks by the scaffold protein Shc1 , 2013, Nature.
[113] J. Ellenberg,et al. The quantitative proteome of a human cell line , 2011, Molecular systems biology.
[114] Krister Wennerberg,et al. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies , 2014, Scientific Reports.
[115] Bin Zhang,et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..
[116] J. Ferrell,et al. Tuning the Activation Threshold of a Kinase Network by Nested Feedback Loops , 2009, Science.
[117] J. Shabanowitz,et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[118] J. Coon,et al. Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling , 2015, Analytical chemistry.
[119] Gautier Koscielny,et al. The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data , 2013, Nucleic Acids Res..
[120] Sean J. Humphrey,et al. Phosphorylation Is a Central Mechanism for Circadian Control of Metabolism and Physiology. , 2017, Cell metabolism.
[121] Sean J. Humphrey,et al. Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry , 2015, Science Signaling.
[122] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.
[123] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[124] J. Fitzgibbon,et al. Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells , 2017, Leukemia.
[125] Blagoy Blagoev,et al. Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs. , 2013, Molecular cell.
[126] J. Doudna,et al. The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.
[127] E. Nishida,et al. A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.
[128] Heiner Koch,et al. The target landscape of clinical kinase drugs , 2017, Science.
[129] Chunaram Choudhary,et al. Proteome-Wide Mapping of the Drosophila Acetylome Demonstrates a High Degree of Conservation of Lysine Acetylation , 2011, Science Signaling.
[130] M. Mann,et al. A large synthetic peptide and phosphopeptide reference library for mass spectrometry–based proteomics , 2013, Nature Biotechnology.
[131] John P. Overington,et al. The promise and peril of chemical probes. , 2015, Nature chemical biology.
[132] Ronald W. Davis,et al. Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.
[133] Bernhard Mlecnik,et al. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data , 2013, Bioinform..
[134] Chad J. Miller,et al. Homing in: Mechanisms of Substrate Targeting by Protein Kinases. , 2018, Trends in biochemical sciences.
[135] Chern Han Yong,et al. Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells , 2018, Science.
[136] T. Pawson,et al. Reading protein modifications with interaction domains , 2006, Nature Reviews Molecular Cell Biology.
[137] Christian von Mering,et al. Cell-wide analysis of protein thermal unfolding reveals determinants of thermostability , 2017, Science.
[138] Danny Reinberg,et al. Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage , 2007, Molecular and Cellular Biology.
[139] M. Mann,et al. Organellar Proteomics and Phospho-Proteomics Reveal Subcellular Reorganization in Diet-Induced Hepatic Steatosis. , 2018, Developmental cell.
[140] Masaru Tomita,et al. Microscale phosphoproteome analysis of 10,000 cells from human cancer cell lines. , 2011, Analytical chemistry.
[141] P. Nordlund,et al. Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay , 2013, Science.
[142] S. Knapp,et al. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases , 2007, Proceedings of the National Academy of Sciences.
[143] Toshifumi Takao,et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases , 2000, Nature.
[144] S. Mohammed,et al. Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. , 2011, Journal of proteome research.
[145] Gary D Bader,et al. The human genome and drug discovery after a decade. Roads (still) not taken , 2011, 1102.0448.
[146] A. Heck,et al. Crosstalk between phosphorylation and O‐GlcNAcylation: friend or foe , 2018, The FEBS journal.
[147] S. Brunak,et al. Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer , 2017, Cell reports.
[148] Edward L. Huttlin,et al. A large-scale method to measure absolute protein phosphorylation stoichiometries , 2011, Nature Methods.
[149] Lars Malmström,et al. Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS , 2017, Nature Biotechnology.
[150] Steven P Gygi,et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[151] S. Brunak,et al. Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.
[152] M. Mann,et al. In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. , 2013, Cell reports.
[153] M. Baccarani,et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. , 2002, The New England journal of medicine.
[154] L. Castagnoli,et al. The human phosphatase interactome: An intricate family portrait , 2012, FEBS letters.
[155] M. Mann,et al. The coming age of complete, accurate, and ubiquitous proteomes. , 2013, Molecular cell.
[156] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[157] Matthias Mann,et al. Revisiting biomarker discovery by plasma proteomics , 2017, Molecular systems biology.
[158] D. Goodlett,et al. Multiplexed and data-independent tandem mass spectrometry for global proteome profiling. , 2014, Mass spectrometry reviews.
[159] Bryan P. Early,et al. A Protease for Middle Down Proteomics , 2012, Nature Methods.
[160] J. Schapansky,et al. The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease , 2015, Neuroscience.
[161] Patrick G. A. Pedrioli,et al. Phosphoproteomic Analysis Reveals Interconnected System-Wide Responses to Perturbations of Kinases and Phosphatases in Yeast , 2010, Science Signaling.
[162] Bernhard Kuster,et al. Comparing immobilized kinase inhibitors and covalent ATP probes for proteomic profiling of kinase expression and drug selectivity. , 2013, Journal of proteome research.
[163] Caleb J Bashor,et al. The Ste5 Scaffold Allosterically Modulates Signaling Output of the Yeast Mating Pathway , 2006, Science.
[164] T. Hunter,et al. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases , 1996, Molecular and cellular biology.
[165] G. Lienhard,et al. Non-functional phosphorylations? , 2008, Trends in biochemical sciences.
[166] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[167] S. Gygi,et al. Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis. , 2011, Molecular cell.
[168] T. McGraw,et al. Development of a new model system to dissect isoform specific Akt signalling in adipocytes , 2015, The Biochemical journal.
[169] K. Shokat,et al. Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3 , 2007, Nature.
[170] Albert J R Heck,et al. Widespread bacterial protein histidine phosphorylation revealed by mass spectrometry-based proteomics , 2018, Nature Methods.
[171] M. Mann,et al. Quantitative Phosphoproteomics Applied to the Yeast Pheromone Signaling Pathway*S , 2005, Molecular & Cellular Proteomics.
[172] Heiner Koch,et al. Phosphoproteome Profiling Reveals Molecular Mechanisms of Growth-Factor-Mediated Kinase Inhibitor Resistance in EGFR-Overexpressing Cancer Cells. , 2016, Journal of proteome research.
[173] Shabaz Mohammed,et al. Comparative Phosphoproteomic Analysis of Checkpoint Recovery Identifies New Regulators of the DNA Damage Response , 2013, Science Signaling.
[174] B. Garcia,et al. Differential quantification of isobaric phosphopeptides using data-independent acquisition mass spectrometry. , 2016, Molecular bioSystems.
[175] S. Fields,et al. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation , 2013, Nature Methods.
[176] J. Ferrell,et al. Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.
[177] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[178] D. James,et al. Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway* , 2015, The Journal of Biological Chemistry.
[179] B. Taylor,et al. Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS , 2017, Nature.
[180] T. Hunter,et al. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.
[181] Ian Collins,et al. Probing the Probes: Fitness Factors For Small Molecule Tools , 2010, Chemistry & biology.
[182] Florian Gnad,et al. Evolutionary Constraints of Phosphorylation in Eukaryotes, Prokaryotes, and Mitochondria* , 2010, Molecular & Cellular Proteomics.
[183] J. Graff,et al. Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism , 2015, Nature Communications.
[184] Yingming Zhao,et al. Metabolic Regulation by Lysine Malonylation, Succinylation, and Glutarylation* , 2015, Molecular & Cellular Proteomics.
[185] Jürg Zimmermann,et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.
[186] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[187] M. Pool,et al. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. , 2001, The Biochemical journal.
[188] K. Shokat,et al. Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction. , 2015, Cell metabolism.
[189] P. Alam. ‘E’ , 2021, Composites Engineering: An A–Z Guide.
[190] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[191] Derek J. Bailey,et al. The One Hour Yeast Proteome* , 2013, Molecular & Cellular Proteomics.
[192] Edwin Smith,et al. The Language of Histone Crosstalk , 2010, Cell.
[193] L. Iakoucheva,et al. The importance of intrinsic disorder for protein phosphorylation. , 2004, Nucleic acids research.
[194] Raymond J. Deshaies,et al. Multisite Phosphorylation and the Countdown to S Phase , 2001, Cell.
[195] J. Coon,et al. Proteome sequencing goes deep. , 2015, Current opinion in chemical biology.
[196] Tony Pawson,et al. Comparative Analysis Reveals Conserved Protein Phosphorylation Networks Implicated in Multiple Diseases , 2009, Science Signaling.
[197] G. Drewes,et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry , 2015, Nature Protocols.
[198] Jianmin Wu,et al. Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer , 2013, Molecular Cancer Therapeutics.
[199] K. Shokat,et al. Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases , 2008, Nature chemical biology.
[200] Karina D. Sørensen,et al. An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes , 2017, Cell systems.
[201] M. Goumans,et al. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair , 2017, Circulation.
[202] D. Iliopoulos,et al. Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. , 2014, Molecular cell.
[203] B. Kemp,et al. Protein kinase recognition sequence motifs. , 1990, Trends in biochemical sciences.
[204] K. Shokat,et al. A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src. , 1998, Bioorganic & medicinal chemistry.
[205] G. Hart,et al. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. , 2011, Annual review of biochemistry.
[206] Matthias Mann,et al. Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis , 2017, eLife.
[207] Nolan J Hoffman,et al. Structural Basis for Phosphorylation and Lysine Acetylation Cross-talk in a Kinase Motif Associated with Myocardial Ischemia and Cardioprotection* , 2014, The Journal of Biological Chemistry.